I agree that this site is using cookies. You can find further informations here.
X
Fries, W
699  results:
Articles (Online) X
Search for persons X
?
1

P539 Assessment of VEdolizumab aNd Ustekinumab in Elderly p..:

Viola, A ; Ventimiglia, M ; Sparacino, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1059-i1061 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P908 Real-life effectiveness and safety of tofacitinib and ..:

Noviello, D ; Savarino, E ; Fries, W...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1660-i1661 , 2024
Link: https://doi.org/10.1093/..
 
?
3

OC.07.2: ASSESSMENT OF VEDOLIZUMAB AND USTEKINUMAB IN ELDER..:

Viola, A. ; Ventimiglia, M. ; Sparacino, A....
Digestive and Liver Disease.  56 (2024)  - p. S161-S163 , 2024
Link: https://doi.org/10.1016/..
 
?
4

T.10.1 SAFETY AND EFFECTIVENESS OF TOFACITINIB IN ULCERATIV..:

Macaluso, F.S. ; D'Antonio, E. ; Fries, W....
Digestive and Liver Disease.  55 (2023)  - p. S178 , 2023
Link: https://doi.org/10.1016/..
 
?
5

T.06.2 USTEKINUMAB IS A PROMISING OPTION FOR THE TREATMENT ..:

Macaluso, F.S. ; Grova, M. ; Mocciaro, F....
Digestive and Liver Disease.  55 (2023)  - p. S159-S160 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P570 Safety and Effectiveness of Tofacitinib in Ulcerative ..:

Macaluso, F S ; D'Antonio, E ; Fries, W...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i697-i698 , 2023
Link: https://doi.org/10.1093/..
 
?
7

P396 Ustekinumab Is A Promising Option For The Treatment Of..:

Macaluso, F S ; Grova, M ; Mocciaro, F...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i528-i528 , 2023
Link: https://doi.org/10.1093/..
 
?
8

T.06.8 COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB A..:

Onali, S. ; Pugliese, D. ; Caprioli, F.A....
Digestive and Liver Disease.  54 (2022)  - p. S140-S141 , 2022
Link: https://doi.org/10.1016/..
 
?
9

OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS..:

Macaluso, F.S. ; Grova, M. ; Saladino, M....
Digestive and Liver Disease.  54 (2022)  - p. S93-S94 , 2022
Link: https://doi.org/10.1016/..
 
?
10

P345 The Effectiveness of Ustekinumab and Vedolizumab as Th..:

Macaluso, F S ; Grova, M ; Saladino, M...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i359-i360 , 2022
Link: https://doi.org/10.1093/..
 
?
11

T.06.7 INCIDENT COLORECTAL CANCER IN INFLAMMATORY BOWEL DIS..:

Neri, B. ; Scribano, M.L. ; Armuzzi, A....
Digestive and Liver Disease.  54 (2022)  - p. S140 , 2022
Link: https://doi.org/10.1016/..
 
?
12

P252 Low adherence is associated with worse disease course ..:

Viola, A ; Demarzo, M G ; Abbruzzese, A...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i295-i296 , 2022
Link: https://doi.org/10.1093/..
 
?
13

P613 Comparative objective effectiveness of vedolizumab and..:

Onali, S ; Pugliese, D ; Caprioli, F A...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i542-i543 , 2022
Link: https://doi.org/10.1093/..
 
?
14

P305 Effectiveness and Safety of Vedolizumab in Biologic-Na..:

Macaluso, F ; Fries, W ; Renna, S...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S333-S333 , 2021
Link: https://doi.org/10.1093/..
 
?
15

P314 TNF gene activation used as criterion to discontinue b..:

Goll, R ; Kay-Martin, J ; Viola, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S340-S341 , 2021
Link: https://doi.org/10.1093/..
 
1-15